Rachel Scott, MD,MPH,FACOG

Scientific Director
MedStar Health Research Institute

Disclosure(s): DHHS Perinatal Guidelines: Board Member; UW STD Prevention Training Center (UW STD PTC): Honoraria; ViiV Healthcare: Advisor/Consultant, Grant/Research Support; Vindico CME: Honoraria

Poster(s):

• (P-500) Awareness and preferences for every 2 month long-acting injectable HIV Pre-Exposure Prophylaxis (PrEP) versus daily oral PrEP among cisgender women in the United States and the Dominican Republic
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT

• (P-1401) Association Between Intimate Partner Violence and Antiretroviral Adherence Among Pregnant Women Living with HIV
  Friday, October 18, 2024

  12:15 PM – 1:30 PM US PT

• (P-1405) Drivers of Unplanned Pregnancy among Women with HIV in the Northern and Southern United States.
  Friday, October 18, 2024

  12:15 PM – 1:30 PM US PT

• (P-1415) Social Determinants of Health and Side Effects Significantly Predict Pre-Exposure Prophylaxis (PrEP) Preferences for Every 2 Month Long-Acting Injectable vs. Daily Oral PrEP among Cisgender Women in the United States and the Dominican Republic
  Friday, October 18, 2024

  12:15 PM – 1:30 PM US PT